Zeon Corporation

Sbi Pharmaceuticals Co., Ltd.

Alpine Electronics, Inc.

Tokyo Institute of Technology

Tokushima University

National Hospital Organization

Takuya Ishii

Tohru Tanaka

Kiwamu Takahashi

Koji Annaka

Katsushi Inoue

Takeshi Suzuki

Keisuke Ito

Takuya Kaneda

Motowo Nakajima

Masahiro Ishizuka

Hiroshi Kido

Maki Mesuda

Azusa Masuda

Kunihiro Goto

Takafumi Sekimoto

Shun-ichiro Ogura

Tsutomu Numata

Mariko Shibuya

Junji Chida

Kazuhiko Yamane

Takato Yoshida

Kazumichi Shimahara

A facial feature detecting apparatus includes a feature sensor configured to acquire information on facial features of a subject; a feature detecting unit configured to detect the facial features of the subject from the information acquired by the feature sensor; a three-dimensional coordinates calculating unit configured to calculate three-dimensional coordinates of the facial features of the subject; and a feature position estimating unit configured to estimate first three-dimensional coordinates of a first facial feature from second three-dimensional coordinates of a second facial feature of the detected facial features, on a basis that the first facial feature and the second facial feature are located at bilaterally symmetrical positions.

Facial feature detecting apparatus and facial feature detecting method

A disclosed binder composition comprises a copolymer which comprises a nitrile group-containing monomer unit, an acidic group-containing monomer unit and a basic group-containing monomer unit, wherein the proportion of the nitrile group-containing monomer unit in the copolymer is 70.0 mol % or more and 99.0 mol % or less, and wherein the total proportion of the acidic group-containing monomer unit and the basic group-containing monomer unit in the copolymer is 0.8 mol % or more and 10.0 mol % or less.

Binder composition for electrochemical device electrode, slurry composition for electrochemical device electrode, electrochemical device electrode, and electrochemical device

Provided is a slurry composition for a non-aqueous secondary battery positive electrode that has excellent stability and enables formation of a positive electrode mixed material layer that causes a non-aqueous secondary battery to display excellent output characteristics. The slurry composition contains a positive electrode active material and a copolymer. The proportion constituted by nickel among transition metal in the positive electrode active material is at least 30.0 mol % and not more than 100.0 mol %. The copolymer includes a nitrile group-containing monomer unit in a proportion of at least 70.0 mass % and not more than 96.0 mass % and a basic group-containing monomer unit in a proportion of at least 0.1 mass % and not more than 5.0 mass %.

Slurry composition for non-aqueous secondary battery positive electrode, positive electrode for non-aqueous secondary battery, and non-aqueous secondary battery

A technique for ensuring the coatability of a slurry composition and also enabling an electrochemical device to exhibit excellent high-voltage cycle characteristics is provided. A binder particle aggregate for an electrochemical device electrode comprises a plurality of binder particles that contain a polymer including 75.0 mol % or more and 99.5 mol % or less of a nitrile group-containing monomer unit, wherein a pore content ratio of the plurality of binder particles is 60% or more.

Binder particle aggregate for electrochemical device electrode, slurry composition for electrochemical device electrode, production methods therefor, electrode for electrochemical device, and electrochemical device

A nozzle part dropping a slurry and a rotary disk centrifugally spraying the slurry to be dropped from the nozzle part are included. The rotary disk includes a plurality of grooves stretching in a radiation direction at least in a periphery part of a surface on which the slurry is sprayed.

Atomizer, spray-drying apparatus, and method for manufacturing composite particles

Provided is a therapeutic agent capable of treating allergic rhinitis in a safe, simple, and noninvasive manner substantially without side effects and physical distress to patients. Provided is a therapeutic agent for allergic rhinitis for 5-aminolevulinic acid-based photodynamic therapy (ALA-PDT) comprising 5-aminolevulinic acid (ALA) or a derivative thereof, or a salt of the 5-aminolevulinic acid or the derivative as an active ingredient, and used in ALA-PDT in which light having a wavelength of 400 nm to 700 nm is irradiated; and particularly provided is a therapeutic agent for allergic rhinitis in a locally applied solution form, a water-soluble ointment-dissolved form, a jelly-dissolved form, or the like. The therapeutic agent does not require the conduct of 5-aminolevulinic acid-based photodynamic diagnosis (ALA-PDD) for detecting a site of protoporphyrin IX (PpIX) accumulation radiating light having a wavelength of 610 nm to 650 nm under irradiation of excitation light having a wavelength of 380 nm to 420 nm before ALA-PDT.

Therapeutic agent for allergic rhinitis

The objects of the present invention are to inhibit photobleaching of porphyrins as well as to provide a superior photodynamic diagnostic agent and a photodynamic diagnostic method employing the photobleaching inhibitor for porphyrins. The present invention provides a photodynamic diagnostic agent containing a precursor of porphyrins and a gallic acid. The present invention also provides a photobleaching inhibitor for porphyrins containing a gallic acid.

Photodynamic diagnostic agent and photobleaching inhibitor

To provide a secondary battery porous membrane that has superior heat resistance and flexibility and contributes to improvements in battery cycle characteristics. Also provided is a secondary battery having high cycle characteristics that uses this porous membrane. [Solution] This secondary battery porous membrane contains nonconductive particles and a binder. The binder is characterized by being formed from a polymer containing a nitrile group, a novel group, and a Cstraight-chain alkylene structural unit in the same molecule and the nitrile group content in the polymer constituting the binder being 1-25% by mass, with the iodine value of the polymer being 0 mg/100 mg-30 mg/100 mg.

Secondary battery porous membrane, slurry for secondary battery porous membrane, and secondary battery

Provided is a prophylactic/therapeutic agent for influenza viral infection that is effective not only before and at an early stage of infection with influenza virus but also at an intermediate or late stage of the infection and is highly safe for human bodies. A prophylactic/therapeutic drug for influenza viral infection comprising, as active ingredients, 5-aminolevulinic acid (5-ALA), a derivative thereof or a salt of the 5-ALA or the derivative, and an iron compound is prepared. This prophylactic/therapeutic agent can be used for ameliorating (preventing) depression in food consumption, water consumption and body weight, for ameliorating (decreasing) increase in ketone body levels in blood that may otherwise cause ketosis, for ameliorating (preventing) depression in ATP levels in blood, or for ameliorating (increasing) a survival rate and depression in a body surface temperature.

Prophylactic/therapeutic agent for influenza virus infection

It is to provide photodynamic therapy (PDT) and photodynamic diagnosis (PDD) which are suitable for the diagnosis and therapy of a part requiring a certain degree of deep penetration, such as subcutaneous cancer and lymph nodes surrounded by blood vessels and fat. This is solved by performing PDT and PDD targeting cancer by administering a composition comprising a photosensitizing agent such as a tetrapyrrole-based compound (photofrin, protoporphyrin IX, etc.) or ALAs such as 5-aminolevulinic acid (ALA), ALA methyl ester, ALA ethyl ester, ALA propyl ester, ALA butyl ester, ALA pentyl ester, or a hydrochloride, phosphate, or sulfate thereof followed by irradiation with excitation light at a wavelength of 480 to 580 nm.

Growing community of inventors

Tokyo, Japan

Takuya Ishii